Wednesday, September 25, 2019
- 1:15pm-2:45pm
-
Mindfulness Based Stress Reduction in People with Parkinson’s Disease and their Carepartners
Non-Pharmacological Interventions · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Misdiagnosis in blepharospasm: the common imitators which should not be missed
Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Mitigation Effects of a Novel Herbal Medicine Hepad, on neurophysiology.
Physiology and Pathophysiology · Les Muses, Level 3
- 1:15pm-2:45pm
-
Mitochondrial Complex 1, Sigma 1 Receptor and Synaptic Vesicle protein 2A density in early de novo patients with Parkinson’s Disease: pilot PET data
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Moaning: genetic analysis of a family with eight affected members
Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Molecular correlates of survival and clinical severity in Progressive Supranuclear Palsy
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Motor and non-motor symptoms differences between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Motor compensation in Parkinson’s disease: a multimodal neuroimaging study
Physiology and Pathophysiology · Les Muses, Level 3
- «Previous Page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- …
- 67
- Next Page»